BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 650342)

  • 1. Interferon in nasal secretions from infants with viral respiratory tract infections.
    McIntosh K
    J Pediatr; 1978 Jul; 93(1):33-6. PubMed ID: 650342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.
    Hall CB; Douglas RG; Simons RL; Geiman JM
    J Pediatr; 1978 Jul; 93(1):28-32. PubMed ID: 206677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.
    McIntosh K; McQuillin J; Gardner PS
    Infect Immun; 1979 Feb; 23(2):276-81. PubMed ID: 422241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon production in adults with respiratory syncytial viral infection.
    Hall CB; Douglas RG; Simons RL
    Ann Intern Med; 1981 Jan; 94(1):53-5. PubMed ID: 6160798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunologic response to infection with respiratory syncytial virus in infants.
    McIntosh K; Masters HB; Orr I; Chao RK; Barkin RM
    J Infect Dis; 1978 Jul; 138(1):24-32. PubMed ID: 355574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
    Murphy BR; Graham BS; Prince GA; Walsh EE; Chanock RM; Karzon DT; Wright PF
    J Clin Microbiol; 1986 Jun; 23(6):1009-14. PubMed ID: 3754878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.
    Welliver RC; Kaul TN; Putnam TI; Sun M; Riddlesberger K; Ogra PL
    J Pediatr; 1980 May; 96(5):808-13. PubMed ID: 7365579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of respiratory syncytial virus diseases in hospitalized children in the district of Steyr 1984/85].
    Emhofer J; Ploier R; Popow-Kraupp T; Brunhuber W
    Padiatr Padol; 1988; 23(1):15-23. PubMed ID: 3260367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response.
    Welliver RC; Sun M; Rinaldo D; Ogra PL
    Pediatr Res; 1985 May; 19(5):420-4. PubMed ID: 4000767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions.
    Cranage MP; Gardner PS; McIntosh K
    Clin Exp Immunol; 1981 Jan; 43(1):28-35. PubMed ID: 7018759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants.
    Melendi GA; Laham FR; Monsalvo AC; Casellas JM; Israele V; Polack NR; Kleeberger SR; Polack FP
    Pediatrics; 2007 Aug; 120(2):e410-5. PubMed ID: 17671045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.
    Welliver TP; Garofalo RP; Hosakote Y; Hintz KH; Avendano L; Sanchez K; Velozo L; Jafri H; Chavez-Bueno S; Ogra PL; McKinney L; Reed JL; Welliver RC
    J Infect Dis; 2007 Apr; 195(8):1126-36. PubMed ID: 17357048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus.
    Waris M; Meurman O; Mufson MA; Ruuskanen O; Halonen P
    J Med Virol; 1992 Oct; 38(2):111-6. PubMed ID: 1460457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.
    Sharma R; Woldehiwet Z
    Epidemiol Infect; 1992 Feb; 108(1):135-45. PubMed ID: 1547834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local antibody response to R.S. virus infection in the respiratory tract.
    Scott R; Gardner PS
    J Hyg (Lond); 1974 Feb; 72(1):111-20. PubMed ID: 4206147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific antibodies in the nasal secretum of children with RS viral affection of lower respiratory pathways (author's transl)].
    Brůcková M; Hrusková J; Kunzová L; Syrůcek L; Pennigerová S; Holanová L
    Cesk Epidemiol Mikrobiol Imunol; 1979 Sep; 28(5):268-75. PubMed ID: 161514
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory syncytial virus infection in transported calves.
    Gillette KG; Smith PC
    Am J Vet Res; 1985 Dec; 46(12):2596-600. PubMed ID: 2417510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus.
    Reuman PD; Keely SP; Schiff GM
    J Med Virol; 1990 Sep; 32(1):67-72. PubMed ID: 2243208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic study of febrile upper respiratory tract infections in adults.
    Shimokata K; Totani Y; Tsunekawa H; Sasou H; Miyachi T
    Jpn J Med; 1988 Aug; 27(3):286-90. PubMed ID: 2848145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease.
    Volovitz B; Welliver RC; De Castro G; Krystofik DA; Ogra PL
    Pediatr Res; 1988 Oct; 24(4):504-7. PubMed ID: 3174295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.